Devoteam SA
Devoteam SA (DVT.PA) Stock Competitors & Peer Comparison
See (DVT.PA) competitors and their performances in Stock Market.
Peer Comparison Table: Information Technology Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| DVT.PA | €168.50 | +0.00% | 0 | 27.49 | €6.13 | N/A |
| IBMA.BR | €145.00 | -0.24% | 132.1B | 61.70 | €2.35 | N/A |
| CAP.PA | €97.88 | +1.75% | 16.4B | 10.72 | €9.13 | +3.47% |
| SOP.PA | €116.10 | +1.22% | 2.3B | 7.66 | €15.16 | +4.01% |
| ATE.PA | €51.60 | -1.24% | 1.8B | 12.03 | €4.29 | +2.91% |
| SII.PA | €70.10 | +0.14% | 1.4B | 15.61 | €4.49 | N/A |
| WAVE.PA | €44.80 | +0.34% | 1.1B | 13.91 | €3.22 | +1.03% |
| SNC.LS | €2.98 | +0.00% | 911.2M | 11.04 | €0.27 | +0.94% |
| NRO.PA | €34.50 | +0.29% | 839.2M | 16.12 | €2.14 | +3.77% |
| GYQ.IR | €28.60 | +0.00% | 665.1M | -25.77 | -€1.11 | N/A |
Stock Comparison
DVT.PA vs IBMA.BR Comparison April 2026
DVT.PA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DVT.PA stands at 0. In comparison, IBMA.BR has a market cap of 132.1B. Regarding current trading prices, DVT.PA is priced at €168.50, while IBMA.BR trades at €145.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DVT.PA currently has a P/E ratio of 27.49, whereas IBMA.BR's P/E ratio is 61.70. In terms of profitability, DVT.PA's ROE is +0.23%, compared to IBMA.BR's ROE of +0.10%. Regarding short-term risk, DVT.PA is less volatile compared to IBMA.BR. This indicates potentially lower risk in terms of short-term price fluctuations for DVT.PA.Check IBMA.BR's competition here
DVT.PA vs CAP.PA Comparison April 2026
DVT.PA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DVT.PA stands at 0. In comparison, CAP.PA has a market cap of 16.4B. Regarding current trading prices, DVT.PA is priced at €168.50, while CAP.PA trades at €97.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DVT.PA currently has a P/E ratio of 27.49, whereas CAP.PA's P/E ratio is 10.72. In terms of profitability, DVT.PA's ROE is +0.23%, compared to CAP.PA's ROE of +0.11%. Regarding short-term risk, DVT.PA is less volatile compared to CAP.PA. This indicates potentially lower risk in terms of short-term price fluctuations for DVT.PA.Check CAP.PA's competition here
DVT.PA vs SOP.PA Comparison April 2026
DVT.PA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DVT.PA stands at 0. In comparison, SOP.PA has a market cap of 2.3B. Regarding current trading prices, DVT.PA is priced at €168.50, while SOP.PA trades at €116.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DVT.PA currently has a P/E ratio of 27.49, whereas SOP.PA's P/E ratio is 7.66. In terms of profitability, DVT.PA's ROE is +0.23%, compared to SOP.PA's ROE of +0.15%. Regarding short-term risk, DVT.PA is less volatile compared to SOP.PA. This indicates potentially lower risk in terms of short-term price fluctuations for DVT.PA.Check SOP.PA's competition here
DVT.PA vs ATE.PA Comparison April 2026
DVT.PA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DVT.PA stands at 0. In comparison, ATE.PA has a market cap of 1.8B. Regarding current trading prices, DVT.PA is priced at €168.50, while ATE.PA trades at €51.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DVT.PA currently has a P/E ratio of 27.49, whereas ATE.PA's P/E ratio is 12.03. In terms of profitability, DVT.PA's ROE is +0.23%, compared to ATE.PA's ROE of +0.05%. Regarding short-term risk, DVT.PA is less volatile compared to ATE.PA. This indicates potentially lower risk in terms of short-term price fluctuations for DVT.PA.Check ATE.PA's competition here
DVT.PA vs SII.PA Comparison April 2026
DVT.PA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DVT.PA stands at 0. In comparison, SII.PA has a market cap of 1.4B. Regarding current trading prices, DVT.PA is priced at €168.50, while SII.PA trades at €70.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DVT.PA currently has a P/E ratio of 27.49, whereas SII.PA's P/E ratio is 15.61. In terms of profitability, DVT.PA's ROE is +0.23%, compared to SII.PA's ROE of +0.33%. Regarding short-term risk, DVT.PA is less volatile compared to SII.PA. This indicates potentially lower risk in terms of short-term price fluctuations for DVT.PA.Check SII.PA's competition here
DVT.PA vs WAVE.PA Comparison April 2026
DVT.PA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DVT.PA stands at 0. In comparison, WAVE.PA has a market cap of 1.1B. Regarding current trading prices, DVT.PA is priced at €168.50, while WAVE.PA trades at €44.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DVT.PA currently has a P/E ratio of 27.49, whereas WAVE.PA's P/E ratio is 13.91. In terms of profitability, DVT.PA's ROE is +0.23%, compared to WAVE.PA's ROE of +0.12%. Regarding short-term risk, DVT.PA is less volatile compared to WAVE.PA. This indicates potentially lower risk in terms of short-term price fluctuations for DVT.PA.Check WAVE.PA's competition here
DVT.PA vs SNC.LS Comparison April 2026
DVT.PA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DVT.PA stands at 0. In comparison, SNC.LS has a market cap of 911.2M. Regarding current trading prices, DVT.PA is priced at €168.50, while SNC.LS trades at €2.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DVT.PA currently has a P/E ratio of 27.49, whereas SNC.LS's P/E ratio is 11.04. In terms of profitability, DVT.PA's ROE is +0.23%, compared to SNC.LS's ROE of +0.04%. Regarding short-term risk, DVT.PA is less volatile compared to SNC.LS. This indicates potentially lower risk in terms of short-term price fluctuations for DVT.PA.Check SNC.LS's competition here
DVT.PA vs NRO.PA Comparison April 2026
DVT.PA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DVT.PA stands at 0. In comparison, NRO.PA has a market cap of 839.2M. Regarding current trading prices, DVT.PA is priced at €168.50, while NRO.PA trades at €34.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DVT.PA currently has a P/E ratio of 27.49, whereas NRO.PA's P/E ratio is 16.12. In terms of profitability, DVT.PA's ROE is +0.23%, compared to NRO.PA's ROE of +0.17%. Regarding short-term risk, DVT.PA is less volatile compared to NRO.PA. This indicates potentially lower risk in terms of short-term price fluctuations for DVT.PA.Check NRO.PA's competition here
DVT.PA vs GYQ.IR Comparison April 2026
DVT.PA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DVT.PA stands at 0. In comparison, GYQ.IR has a market cap of 665.1M. Regarding current trading prices, DVT.PA is priced at €168.50, while GYQ.IR trades at €28.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DVT.PA currently has a P/E ratio of 27.49, whereas GYQ.IR's P/E ratio is -25.77. In terms of profitability, DVT.PA's ROE is +0.23%, compared to GYQ.IR's ROE of +0.97%. Regarding short-term risk, DVT.PA is less volatile compared to GYQ.IR. This indicates potentially lower risk in terms of short-term price fluctuations for DVT.PA.Check GYQ.IR's competition here
DVT.PA vs ATO.PA Comparison April 2026
DVT.PA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DVT.PA stands at 0. In comparison, ATO.PA has a market cap of 652.1M. Regarding current trading prices, DVT.PA is priced at €168.50, while ATO.PA trades at €33.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DVT.PA currently has a P/E ratio of 27.49, whereas ATO.PA's P/E ratio is -0.45. In terms of profitability, DVT.PA's ROE is +0.23%, compared to ATO.PA's ROE of +3.20%. Regarding short-term risk, DVT.PA is less volatile compared to ATO.PA. This indicates potentially lower risk in terms of short-term price fluctuations for DVT.PA.Check ATO.PA's competition here
DVT.PA vs NEDAP.AS Comparison April 2026
DVT.PA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DVT.PA stands at 0. In comparison, NEDAP.AS has a market cap of 520.3M. Regarding current trading prices, DVT.PA is priced at €168.50, while NEDAP.AS trades at €78.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DVT.PA currently has a P/E ratio of 27.49, whereas NEDAP.AS's P/E ratio is 21.16. In terms of profitability, DVT.PA's ROE is +0.23%, compared to NEDAP.AS's ROE of +0.30%. Regarding short-term risk, DVT.PA is less volatile compared to NEDAP.AS. This indicates potentially lower risk in terms of short-term price fluctuations for DVT.PA.Check NEDAP.AS's competition here
DVT.PA vs AUB.PA Comparison April 2026
DVT.PA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DVT.PA stands at 0. In comparison, AUB.PA has a market cap of 515.9M. Regarding current trading prices, DVT.PA is priced at €168.50, while AUB.PA trades at €40.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DVT.PA currently has a P/E ratio of 27.49, whereas AUB.PA's P/E ratio is 14.84. In terms of profitability, DVT.PA's ROE is +0.23%, compared to AUB.PA's ROE of +0.13%. Regarding short-term risk, DVT.PA is less volatile compared to AUB.PA. This indicates potentially lower risk in terms of short-term price fluctuations for DVT.PA.Check AUB.PA's competition here
DVT.PA vs ORDI.AS Comparison April 2026
DVT.PA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DVT.PA stands at 0. In comparison, ORDI.AS has a market cap of 513.1M. Regarding current trading prices, DVT.PA is priced at €168.50, while ORDI.AS trades at €5.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DVT.PA currently has a P/E ratio of 27.49, whereas ORDI.AS's P/E ratio is 23.75. In terms of profitability, DVT.PA's ROE is +0.23%, compared to ORDI.AS's ROE of +0.14%. Regarding short-term risk, DVT.PA is less volatile compared to ORDI.AS. This indicates potentially lower risk in terms of short-term price fluctuations for DVT.PA.Check ORDI.AS's competition here
DVT.PA vs NBA.LS Comparison April 2026
DVT.PA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DVT.PA stands at 0. In comparison, NBA.LS has a market cap of 339.4M. Regarding current trading prices, DVT.PA is priced at €168.50, while NBA.LS trades at €9.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DVT.PA currently has a P/E ratio of 27.49, whereas NBA.LS's P/E ratio is 33.33. In terms of profitability, DVT.PA's ROE is +0.23%, compared to NBA.LS's ROE of +0.14%. Regarding short-term risk, DVT.PA is less volatile compared to NBA.LS. This indicates potentially lower risk in terms of short-term price fluctuations for DVT.PA.Check NBA.LS's competition here
DVT.PA vs SQI.PA Comparison April 2026
DVT.PA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DVT.PA stands at 0. In comparison, SQI.PA has a market cap of 251.6M. Regarding current trading prices, DVT.PA is priced at €168.50, while SQI.PA trades at €54.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DVT.PA currently has a P/E ratio of 27.49, whereas SQI.PA's P/E ratio is 55.10. In terms of profitability, DVT.PA's ROE is +0.23%, compared to SQI.PA's ROE of +0.04%. Regarding short-term risk, DVT.PA is more volatile compared to SQI.PA. This indicates potentially higher risk in terms of short-term price fluctuations for DVT.PA.Check SQI.PA's competition here
DVT.PA vs INF.PA Comparison April 2026
DVT.PA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DVT.PA stands at 0. In comparison, INF.PA has a market cap of 247.1M. Regarding current trading prices, DVT.PA is priced at €168.50, while INF.PA trades at €35.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DVT.PA currently has a P/E ratio of 27.49, whereas INF.PA's P/E ratio is 15.17. In terms of profitability, DVT.PA's ROE is +0.23%, compared to INF.PA's ROE of +0.20%. Regarding short-term risk, DVT.PA is less volatile compared to INF.PA. This indicates potentially lower risk in terms of short-term price fluctuations for DVT.PA.Check INF.PA's competition here
DVT.PA vs ECONB.BR Comparison April 2026
DVT.PA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DVT.PA stands at 0. In comparison, ECONB.BR has a market cap of 228.4M. Regarding current trading prices, DVT.PA is priced at €168.50, while ECONB.BR trades at €1.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DVT.PA currently has a P/E ratio of 27.49, whereas ECONB.BR's P/E ratio is 4.25. In terms of profitability, DVT.PA's ROE is +0.23%, compared to ECONB.BR's ROE of +0.01%. Regarding short-term risk, DVT.PA is less volatile compared to ECONB.BR. This indicates potentially lower risk in terms of short-term price fluctuations for DVT.PA.Check ECONB.BR's competition here
DVT.PA vs MLCNT.PA Comparison April 2026
DVT.PA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DVT.PA stands at 0. In comparison, MLCNT.PA has a market cap of 145.3M. Regarding current trading prices, DVT.PA is priced at €168.50, while MLCNT.PA trades at €66.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DVT.PA currently has a P/E ratio of 27.49, whereas MLCNT.PA's P/E ratio is N/A. In terms of profitability, DVT.PA's ROE is +0.23%, compared to MLCNT.PA's ROE of +0.18%. Regarding short-term risk, DVT.PA is less volatile compared to MLCNT.PA. This indicates potentially lower risk in terms of short-term price fluctuations for DVT.PA.Check MLCNT.PA's competition here
DVT.PA vs MLCHE.PA Comparison April 2026
DVT.PA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DVT.PA stands at 0. In comparison, MLCHE.PA has a market cap of 130M. Regarding current trading prices, DVT.PA is priced at €168.50, while MLCHE.PA trades at €56.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DVT.PA currently has a P/E ratio of 27.49, whereas MLCHE.PA's P/E ratio is 14.20. In terms of profitability, DVT.PA's ROE is +0.23%, compared to MLCHE.PA's ROE of +0.24%. Regarding short-term risk, DVT.PA is more volatile compared to MLCHE.PA. This indicates potentially higher risk in terms of short-term price fluctuations for DVT.PA.Check MLCHE.PA's competition here
DVT.PA vs GLINT.LS Comparison April 2026
DVT.PA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DVT.PA stands at 0. In comparison, GLINT.LS has a market cap of 114.8M. Regarding current trading prices, DVT.PA is priced at €168.50, while GLINT.LS trades at €1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DVT.PA currently has a P/E ratio of 27.49, whereas GLINT.LS's P/E ratio is 16.50. In terms of profitability, DVT.PA's ROE is +0.23%, compared to GLINT.LS's ROE of +0.09%. Regarding short-term risk, DVT.PA is less volatile compared to GLINT.LS. This indicates potentially lower risk in terms of short-term price fluctuations for DVT.PA.Check GLINT.LS's competition here
DVT.PA vs ALKEY.PA Comparison April 2026
DVT.PA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DVT.PA stands at 0. In comparison, ALKEY.PA has a market cap of 111.3M. Regarding current trading prices, DVT.PA is priced at €168.50, while ALKEY.PA trades at €7.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DVT.PA currently has a P/E ratio of 27.49, whereas ALKEY.PA's P/E ratio is 7.53. In terms of profitability, DVT.PA's ROE is +0.23%, compared to ALKEY.PA's ROE of +0.22%. Regarding short-term risk, DVT.PA is less volatile compared to ALKEY.PA. This indicates potentially lower risk in terms of short-term price fluctuations for DVT.PA.Check ALKEY.PA's competition here
DVT.PA vs ALMIC.PA Comparison April 2026
DVT.PA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DVT.PA stands at 0. In comparison, ALMIC.PA has a market cap of 84.1M. Regarding current trading prices, DVT.PA is priced at €168.50, while ALMIC.PA trades at €3.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DVT.PA currently has a P/E ratio of 27.49, whereas ALMIC.PA's P/E ratio is 312.00. In terms of profitability, DVT.PA's ROE is +0.23%, compared to ALMIC.PA's ROE of +0.00%. Regarding short-term risk, DVT.PA is less volatile compared to ALMIC.PA. This indicates potentially lower risk in terms of short-term price fluctuations for DVT.PA.Check ALMIC.PA's competition here
DVT.PA vs S30.PA Comparison April 2026
DVT.PA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DVT.PA stands at 0. In comparison, S30.PA has a market cap of 70.1M. Regarding current trading prices, DVT.PA is priced at €168.50, while S30.PA trades at €0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DVT.PA currently has a P/E ratio of 27.49, whereas S30.PA's P/E ratio is -2.62. In terms of profitability, DVT.PA's ROE is +0.23%, compared to S30.PA's ROE of -0.32%. Regarding short-term risk, DVT.PA is less volatile compared to S30.PA. This indicates potentially lower risk in terms of short-term price fluctuations for DVT.PA.Check S30.PA's competition here
DVT.PA vs ALMII.PA Comparison April 2026
DVT.PA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DVT.PA stands at 0. In comparison, ALMII.PA has a market cap of 48.5M. Regarding current trading prices, DVT.PA is priced at €168.50, while ALMII.PA trades at €8.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DVT.PA currently has a P/E ratio of 27.49, whereas ALMII.PA's P/E ratio is 23.47. In terms of profitability, DVT.PA's ROE is +0.23%, compared to ALMII.PA's ROE of +0.09%. Regarding short-term risk, DVT.PA is more volatile compared to ALMII.PA. This indicates potentially higher risk in terms of short-term price fluctuations for DVT.PA.Check ALMII.PA's competition here
DVT.PA vs CTAC.AS Comparison April 2026
DVT.PA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DVT.PA stands at 0. In comparison, CTAC.AS has a market cap of 37.8M. Regarding current trading prices, DVT.PA is priced at €168.50, while CTAC.AS trades at €2.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DVT.PA currently has a P/E ratio of 27.49, whereas CTAC.AS's P/E ratio is 10.68. In terms of profitability, DVT.PA's ROE is +0.23%, compared to CTAC.AS's ROE of +0.11%. Regarding short-term risk, DVT.PA is more volatile compared to CTAC.AS. This indicates potentially higher risk in terms of short-term price fluctuations for DVT.PA.Check CTAC.AS's competition here
DVT.PA vs ALITL.PA Comparison April 2026
DVT.PA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DVT.PA stands at 0. In comparison, ALITL.PA has a market cap of 25.6M. Regarding current trading prices, DVT.PA is priced at €168.50, while ALITL.PA trades at €15.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DVT.PA currently has a P/E ratio of 27.49, whereas ALITL.PA's P/E ratio is 7.04. In terms of profitability, DVT.PA's ROE is +0.23%, compared to ALITL.PA's ROE of +0.09%. Regarding short-term risk, DVT.PA is less volatile compared to ALITL.PA. This indicates potentially lower risk in terms of short-term price fluctuations for DVT.PA.Check ALITL.PA's competition here
DVT.PA vs ALHIT.PA Comparison April 2026
DVT.PA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DVT.PA stands at 0. In comparison, ALHIT.PA has a market cap of 21.4M. Regarding current trading prices, DVT.PA is priced at €168.50, while ALHIT.PA trades at €13.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DVT.PA currently has a P/E ratio of 27.49, whereas ALHIT.PA's P/E ratio is 13.27. In terms of profitability, DVT.PA's ROE is +0.23%, compared to ALHIT.PA's ROE of +0.32%. Regarding short-term risk, DVT.PA is more volatile compared to ALHIT.PA. This indicates potentially higher risk in terms of short-term price fluctuations for DVT.PA.Check ALHIT.PA's competition here
DVT.PA vs AMUND.AS Comparison April 2026
DVT.PA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DVT.PA stands at 0. In comparison, AMUND.AS has a market cap of 17.9M. Regarding current trading prices, DVT.PA is priced at €168.50, while AMUND.AS trades at €0.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DVT.PA currently has a P/E ratio of 27.49, whereas AMUND.AS's P/E ratio is -15.33. In terms of profitability, DVT.PA's ROE is +0.23%, compared to AMUND.AS's ROE of -0.10%. Regarding short-term risk, DVT.PA is less volatile compared to AMUND.AS. This indicates potentially lower risk in terms of short-term price fluctuations for DVT.PA.Check AMUND.AS's competition here
DVT.PA vs FPG.PA Comparison April 2026
DVT.PA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DVT.PA stands at 0. In comparison, FPG.PA has a market cap of 5.7M. Regarding current trading prices, DVT.PA is priced at €168.50, while FPG.PA trades at €0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DVT.PA currently has a P/E ratio of 27.49, whereas FPG.PA's P/E ratio is 0.48. In terms of profitability, DVT.PA's ROE is +0.23%, compared to FPG.PA's ROE of -10.04%. Regarding short-term risk, DVT.PA is less volatile compared to FPG.PA. This indicates potentially lower risk in terms of short-term price fluctuations for DVT.PA.Check FPG.PA's competition here
DVT.PA vs MLLOI.PA Comparison April 2026
DVT.PA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DVT.PA stands at 0. In comparison, MLLOI.PA has a market cap of 5M. Regarding current trading prices, DVT.PA is priced at €168.50, while MLLOI.PA trades at €13.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DVT.PA currently has a P/E ratio of 27.49, whereas MLLOI.PA's P/E ratio is -3.72. In terms of profitability, DVT.PA's ROE is +0.23%, compared to MLLOI.PA's ROE of -0.24%. Regarding short-term risk, DVT.PA is less volatile compared to MLLOI.PA. This indicates potentially lower risk in terms of short-term price fluctuations for DVT.PA.Check MLLOI.PA's competition here
DVT.PA vs RED.LS Comparison April 2026
DVT.PA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DVT.PA stands at 0. In comparison, RED.LS has a market cap of 1M. Regarding current trading prices, DVT.PA is priced at €168.50, while RED.LS trades at €0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DVT.PA currently has a P/E ratio of 27.49, whereas RED.LS's P/E ratio is 0.30. In terms of profitability, DVT.PA's ROE is +0.23%, compared to RED.LS's ROE of -0.18%. Regarding short-term risk, DVT.PA is less volatile compared to RED.LS. This indicates potentially lower risk in terms of short-term price fluctuations for DVT.PA.Check RED.LS's competition here
DVT.PA vs TES.PA Comparison April 2026
DVT.PA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DVT.PA stands at 0. In comparison, TES.PA has a market cap of 0. Regarding current trading prices, DVT.PA is priced at €168.50, while TES.PA trades at €168.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DVT.PA currently has a P/E ratio of 27.49, whereas TES.PA's P/E ratio is 46.37. In terms of profitability, DVT.PA's ROE is +0.23%, compared to TES.PA's ROE of +0.12%. Regarding short-term risk, DVT.PA is more volatile compared to TES.PA. This indicates potentially higher risk in terms of short-term price fluctuations for DVT.PA.Check TES.PA's competition here
DVT.PA vs MUN.PA Comparison April 2026
DVT.PA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DVT.PA stands at 0. In comparison, MUN.PA has a market cap of 0. Regarding current trading prices, DVT.PA is priced at €168.50, while MUN.PA trades at €1.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DVT.PA currently has a P/E ratio of 27.49, whereas MUN.PA's P/E ratio is 12.22. In terms of profitability, DVT.PA's ROE is +0.23%, compared to MUN.PA's ROE of +0.00%. Regarding short-term risk, DVT.PA is less volatile compared to MUN.PA. This indicates potentially lower risk in terms of short-term price fluctuations for DVT.PA.Check MUN.PA's competition here
DVT.PA vs ALUMS.PA Comparison April 2026
DVT.PA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DVT.PA stands at 0. In comparison, ALUMS.PA has a market cap of 0. Regarding current trading prices, DVT.PA is priced at €168.50, while ALUMS.PA trades at €17.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DVT.PA currently has a P/E ratio of 27.49, whereas ALUMS.PA's P/E ratio is 24.86. In terms of profitability, DVT.PA's ROE is +0.23%, compared to ALUMS.PA's ROE of +0.14%. Regarding short-term risk, DVT.PA and ALUMS.PA have similar daily volatility (0.06).Check ALUMS.PA's competition here
DVT.PA vs NOVI.AS Comparison April 2026
DVT.PA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DVT.PA stands at 0. In comparison, NOVI.AS has a market cap of 0. Regarding current trading prices, DVT.PA is priced at €168.50, while NOVI.AS trades at €1.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DVT.PA currently has a P/E ratio of 27.49, whereas NOVI.AS's P/E ratio is 25.00. In terms of profitability, DVT.PA's ROE is +0.23%, compared to NOVI.AS's ROE of -0.03%. Regarding short-term risk, DVT.PA is less volatile compared to NOVI.AS. This indicates potentially lower risk in terms of short-term price fluctuations for DVT.PA.Check NOVI.AS's competition here
DVT.PA vs AKA.PA Comparison April 2026
DVT.PA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DVT.PA stands at 0. In comparison, AKA.PA has a market cap of 0. Regarding current trading prices, DVT.PA is priced at €168.50, while AKA.PA trades at €48.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DVT.PA currently has a P/E ratio of 27.49, whereas AKA.PA's P/E ratio is -85.70. In terms of profitability, DVT.PA's ROE is +0.23%, compared to AKA.PA's ROE of -0.35%. Regarding short-term risk, DVT.PA is less volatile compared to AKA.PA. This indicates potentially lower risk in terms of short-term price fluctuations for DVT.PA.Check AKA.PA's competition here
DVT.PA vs OPN.PA Comparison April 2026
DVT.PA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DVT.PA stands at 0. In comparison, OPN.PA has a market cap of 0. Regarding current trading prices, DVT.PA is priced at €168.50, while OPN.PA trades at €33.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DVT.PA currently has a P/E ratio of 27.49, whereas OPN.PA's P/E ratio is 26.48. In terms of profitability, DVT.PA's ROE is +0.23%, compared to OPN.PA's ROE of +0.04%. Regarding short-term risk, DVT.PA is more volatile compared to OPN.PA. This indicates potentially higher risk in terms of short-term price fluctuations for DVT.PA.Check OPN.PA's competition here